Actemra

tocilizumab · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

127 regulatory and trial events tracked for Actemra, covering 2009-10-27 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma [Phase 2]